• LifeStance Health’s Q3 2026 net income rose year over year to $22.4 million.
• Revenue climbed 25% to $455.9 million, driven primarily by higher visit volumes, improved clinician productivity and higher revenue per visit.
• The clinician base expanded 11% year over year to 8,863, including a sequential net increase of 321.
• Full-year 2026 revenue expectations were raised to $1.74 billion–$1.76 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611050600PRIMZONEFULLFEED9870931) on November 05, 2026, and is solely responsible for the information contained therein.